Filing metadata

Accession number
0001127602-22-022149
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Sep 07, 2022
Reporting period
Sep 06, 2022
Description
Insider transaction

Explore SEC Filings Hub